Hahn Capital Management LLC Has $39.28 Million Stake in Agilent Technologies (NYSE:A)

Hahn Capital Management LLC lowered its stake in Agilent Technologies (NYSE:A) by 2.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 586,518 shares of the medical research company’s stock after selling 12,263 shares during the quarter. Agilent Technologies comprises 3.7% of Hahn Capital Management LLC’s portfolio, making the stock its 10th largest position. Hahn Capital Management LLC owned about 0.18% of Agilent Technologies worth $39,279,000 as of its most recent filing with the SEC.

Other hedge funds also recently bought and sold shares of the company. Nationwide Fund Advisors lifted its holdings in shares of Agilent Technologies by 132.5% in the 3rd quarter. Nationwide Fund Advisors now owns 575,282 shares of the medical research company’s stock worth $36,933,000 after purchasing an additional 327,822 shares during the last quarter. Prudential Financial Inc. raised its stake in Agilent Technologies by 0.5% during the 3rd quarter. Prudential Financial Inc. now owns 459,983 shares of the medical research company’s stock valued at $29,531,000 after acquiring an additional 2,480 shares in the last quarter. Jennison Associates LLC raised its stake in Agilent Technologies by 820.0% during the 3rd quarter. Jennison Associates LLC now owns 32,834 shares of the medical research company’s stock valued at $2,108,000 after acquiring an additional 29,265 shares in the last quarter. FDx Advisors Inc. raised its stake in Agilent Technologies by 17.7% during the 3rd quarter. FDx Advisors Inc. now owns 14,432 shares of the medical research company’s stock valued at $927,000 after acquiring an additional 2,170 shares in the last quarter. Finally, New York State Common Retirement Fund raised its stake in Agilent Technologies by 2.4% during the 3rd quarter. New York State Common Retirement Fund now owns 772,192 shares of the medical research company’s stock valued at $49,575,000 after acquiring an additional 18,400 shares in the last quarter.

How to Become a New Pot Stock Millionaire

Several equities analysts have recently issued reports on the company. Morgan Stanley lifted their price target on Agilent Technologies from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Monday, April 2nd. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a research report on Wednesday. ValuEngine upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. JPMorgan Chase lifted their target price on Agilent Technologies from $75.00 to $80.00 and gave the stock an “overweight” rating in a report on Thursday, February 15th. Finally, Robert W. Baird restated a “buy” rating and issued a $76.00 target price on shares of Agilent Technologies in a report on Thursday, January 18th. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Agilent Technologies currently has a consensus rating of “Buy” and an average price target of $72.48.

Shares of NYSE:A opened at $63.65 on Friday. Agilent Technologies has a fifty-two week low of $52.31 and a fifty-two week high of $75.00. The company has a quick ratio of 2.78, a current ratio of 3.23 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $21,180.22, a price-to-earnings ratio of 26.27, a P/E/G ratio of 2.18 and a beta of 1.31.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 14th. The medical research company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.08. Agilent Technologies had a return on equity of 17.70% and a net margin of 4.25%. The business had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.16 billion. During the same quarter in the previous year, the firm earned $0.53 EPS. analysts predict that Agilent Technologies will post 2.7 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 25th. Investors of record on Tuesday, April 3rd will be paid a dividend of $0.149 per share. The ex-dividend date is Monday, April 2nd. This represents a $0.60 annualized dividend and a yield of 0.94%. Agilent Technologies’s dividend payout ratio is 25.42%.

In other news, insider Patrick Kaltenbach sold 6,875 shares of the company’s stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $71.38, for a total value of $490,737.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Michael R. Mcmullen sold 21,850 shares of the business’s stock in a transaction that occurred on Thursday, January 18th. The stock was sold at an average price of $72.50, for a total value of $1,584,125.00. Following the completion of the transaction, the chief executive officer now directly owns 324,687 shares in the company, valued at $23,539,807.50. The disclosure for this sale can be found here. Insiders have sold 66,400 shares of company stock worth $4,809,327 over the last 90 days.

TRADEMARK VIOLATION NOTICE: “Hahn Capital Management LLC Has $39.28 Million Stake in Agilent Technologies (NYSE:A)” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/07/hahn-capital-management-llc-sells-12263-shares-of-agilent-technologies-inc-a.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply